RECICARD Tablets

A Novel First-line Calcium Channel Blocker for Hypertension Management

COMPOSITION – Cilnidipine IP 10 mg

Category:

Description

Researchers recommend Cilnidipine as a novel first-line CCB for the management of hypertension either as a monotherapy or as a combination therapy. Cilnidipine is highly lipophilic and shows low BP variability among CCBs. The organ protection, especially the reno-protective effect of Cilnidipine deserves special attention.  

COMPOSITION

Cilnidipine

  • Class of medications: Calcium channel blockers

>It is a new antihypertensive drug distinguished from other L-type Ca2+ channel blockers.

> More effective than amlodipine at improving renal function and arterial stiffness in patients with essential.

>Has an anti-proteinuric effect especially in patients with essential hypertension.

> Treats mild to moderate essential hypertension.

Composition

Cilnidipine IP 10 mg

Indications

  1. Cilnidipine is expected to be favorable for various types of complications of hypertension.